Entero Therapeutics Inc. (ENTO)
0.59
0.00 (0.20%)
At close: Jan 14, 2025, 3:58 PM
0.56
-5.85%
After-hours Jan 14, 2025, 03:59 PM EST
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 |
| Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Cost of Revenue | 29.27K | 106.21K | 537.40K | 571.14K | 976.98K | 798.45K | 754.00K | 734.50K | n/a | n/a | n/a |
| Gross Profit | -29.27K | -106.21K | -537.40K | -571.14K | -976.98K | -798.45K | -754.00K | -734.50K | n/a | n/a | n/a |
| Operating Income | -15.77M | -12.68M | -59.06M | -26.43M | -14.74K | -13.22K | -10.08K | -6.63K | -4.73K | -2.92K | -969.41 |
| Interest Income | 2.53K | 8.41K | 1.17K | 484.00 | n/a | 101.85 | 875.20 | 5.94K | 1.59K | 68.15 | n/a |
| Pretax Income | -15.79M | -14.63M | -58.54M | -32.67M | -15.18K | -13.53K | -11.10K | -14.59K | -5.93K | -2.95K | -1.01K |
| Net Income | -15.79M | -14.63M | -58.54M | -32.67M | -15.18M | -13.53M | -11.10M | -14.59M | -5.93M | -2.37M | -1.01K |
| Selling & General & Admin | 10.74M | 11.99M | 18.38M | 7.29M | 6.06K | 7.45K | 7.69K | 4.13K | 3.33K | 1.87K | 536.55 |
| Research & Development | 5.03M | 691.26K | 38.32M | 19.14M | 8.68K | 5.77K | 2.40K | 2.50K | 1.40K | 1.05K | 432.86 |
| Other Expenses | n/a | -232.74K | 529.10K | 211.43K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Operating Expenses | 15.77M | 12.68M | 56.70M | 26.43M | 14.74K | 13.43K | 10.22K | 8.65K | 4.34K | 2.88K | 1.01K |
| Interest Expense | 22.46K | 15.88K | 11.23K | 5.84M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Cost & Expenses | 15.77M | 12.68M | 56.70M | 26.43M | 14.74K | 13.43K | 10.22K | 8.65K | 4.34K | 2.88K | 1.01K |
| Income Tax | n/a | 126.56K | 26.52M | 15.11M | n/a | n/a | n/a | n/a | n/a | -587.21 | n/a |
| Shares Outstanding (Basic) | 336.34K | 35.91K | 2.13K | 677.05 | 533.94 | 367.60 | 253.07 | 154.88 | 232.74 | 232.74 | n/a |
| Shares Outstanding (Diluted) | 336.34K | 35.91K | 2.13K | 677.05 | 533.94 | 367.60 | 253.07 | 154.88 | 232.74 | 232.74 | n/a |
| EPS (Basic) | -47.88 | -416.93 | -39.77K | -61.64K | -28.43K | -36.81K | -43.68K | -94.08K | -25.48K | -10.16K | n/a |
| EPS (Diluted) | -47.88 | -416.93 | -39.77K | -61.64K | -28.43K | -36.81K | -43.68K | -94.08K | -25.48K | -10.16K | n/a |
| EBITDA | -15.74M | -14.51M | -57.99M | -26.26M | -13.77M | -12.63M | -9.47M | -7.92M | -3.61M | -1.87M | -957.65 |
| Depreciation & Amortization | 29.27K | 29.27K | 542.25K | 565.35K | 635.05 | 798.45 | 754.00 | 734.50 | 733.60 | 434.09 | 11.76 |